Old Web
English
Sign In
Acemap
>
authorDetail
>
Jennifer Arrondeau
Jennifer Arrondeau
University of Paris
Medicine
Nivolumab
Therapeutic drug monitoring
Selected reaction monitoring
Erlotinib
4
Papers
34
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Selpercatinib-Enhanced Radioiodine Uptake in RET-Rearranged Thyroid Cancer.
2021
Thyroid
Lionel Groussin
Laura Bessiene
Jennifer Arrondeau
Simon Garinet
Béatrix Cochand-Priollet
Audrey Lupo
Jeremie Zerbit
Jérôme Clerc
Olivier Huillard
Show All
Source
Cite
Save
Citations (1)
Le nivolumab augmente la pression artérielle pulmonaire chez les patients traités pour carcinome pulmonaire non à petites cellules
2021
Revue des Maladies Respiratoires Actualités
Ludovic Fournel
Pascaline Boudou-Rouquette
Mathilde Prieto
C. Guinet
Jennifer Arrondeau
Diane Damotte
Marie Wislez
Frédéric Batteux
Philippe Icard
François Goldwasser
Marco Alifano
Show All
Source
Cite
Save
Citations (0)
Nivolumab increases pulmonary artery pressure in patients treated for non-small cell lung cancer
2020
Cancer Chemotherapy and Pharmacology
Ludovic Fournel
Pascaline Boudou-Rouquette
Mathilde Prieto
Rémi Hervochon
Claude Guinet
Jennifer Arrondeau
Jérôme Alexandre
Diane Damotte
Marie Wislez
Frédéric Batteux
Philippe Icard
François Goldwasser
Marco Alifano
Show All
Source
Cite
Save
Citations (3)
Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients
2018
Journal of Pharmaceutical and Biomedical Analysis
Rafael Reis
Laurence Labat
Marie Allard
Pascaline Boudou-Rouquette
Jeanne Chapron
Audrey Bellesoeur
Audrey Thomas-Schoemann
Jennifer Arrondeau
Frédérique Giraud
J. Alexandre
Michel Vidal
François Goldwasser
Benoit Blanchet
Show All
Source
Cite
Save
Citations (30)
1